Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1295b is a member of the microRNA family, a large class of endogenous, small (~22 nucleotides), non-coding RNAs in eukaryotes. MicroRNAs function in post-transcriptional gene silencing by binding to complementary sites in target mRNAs, leading to translational inhibition or mRNA degradation. While the broad functions of microRNAs in cancer, apoptosis, cell proliferation, and other biological pathways are well established, detailed functional, disease-role, and drug interaction data for miR-1295b are not available in the current literature. No information suggests miR-1295b is a direct therapeutic target such as a receptor, enzyme, or similar protein. The presence of "MIR1295B" in some databases appears to refer to a gene encoding the precursor of miR-1295b, but detailed biological data specific to this microRNA is lacking in key databases and scientific reviews, suggesting that it is not a widely studied or validated target. Additional notes on correctness: There is no strong evidence in the provided or commonly available sources that miR-1295b (hsa-miR-1295b) is a recognized, distinct therapeutic target, nor that it is prominent in disease or as a biomarker. The absence of data, conflicting notability, and lack of functional detail suggests this entry may be incomplete or not a canonical target. If the query is meant to map to a protein, enzyme, receptor, or characterized microRNA with extensive biological and therapeutic data, MIR1295B/hsa-miR-1295b may be incorrect, incomplete, or of ambiguous notability.
Not applicable for direct targeting by drugs (microRNAs themselves are not typically targeted by classic small molecules; they act by binding to complementary mRNA sequences to inhibit their translation or promote degradation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1295b (miR-1295b).